谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase 1/2 Study of FOG-001, a First-in-class Direct Β-Catenin:Tcf Inhibitor, in Patients with Colorectal Cancer, Hepatocellular Carcinoma, and Other Locally Advanced or Metastatic Solid Tumors.

Kyriakos P. Papadopoulos,Michael Cecchini,Moh'd M. Khushman,Meredith Pelster,Jordi Rodon Ahnert,Shivaani Kummar,Rona Yaeger,Sunil Sharma, Amber L. Wells, Amanda Garofalo,Lalith V Akella, Ziyang Yu, Varsha Iyer, Marie Huong Nguyen,Keith W. Orford,Samuel J. Klempner

Journal of Clinical Oncology（2025）

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要